Department of Biomedical Engineering, University of California, Davis, Davis, CA, USA.
Department of Biomedical Engineering, University of California, Davis, Davis, CA, USA; Department of Physics, Norwegian University of Science and Technology, NTNU, Trondheim, Norway.
Acta Biomater. 2019 Sep 15;96:20-34. doi: 10.1016/j.actbio.2019.07.014. Epub 2019 Jul 11.
The prevalence and cost of disorders affecting the musculoskeletal system are predicted to rise significantly in the coming years due to the aging global population and the increase of associated risk factors. Despite being the second largest cause of disability, the clinical options for therapeutic intervention remain limited. The clinical translation of cell-based therapies for the treatment of musculoskeletal disorders faces many challenges including maintenance of cell survival in the harsh in vivo environment and the lack of control over regulating cell phenotype upon implantation. In order to address these challenges, the development of bio-instructive materials to modulate cell behavior has taken center stage as a strategy to increase the therapeutic potential of various cell populations. However, the determination of the necessary cues for a specific application and how these signals should be presented from a biomaterial remains elusive. This review highlights recent biochemical and physical strategies used to engineer bio-instructive materials for the repair of musculoskeletal tissues. There is a particular emphasis on emerging efforts such as the engineering of immunomodulatory and antibacterial materials, as well as the incorporation of these strategies into biofabrication and organ-on-a-chip approaches. STATEMENT OF SIGNIFICANCE: Disorders affecting the musculoskeletal system affect individuals across the lifespan and have a profound effect on mobility and quality of life. While small defects in many tissues can heal successfully, larger defects are often unable to heal or instead heal with inferior quality fibrous tissue and require clinical intervention. Cell-based therapies are a promising option for clinical translation, yet challenges related to maintaining cell survival and instructing cell phenotype upon implantation have limited the success of this approach. Bio-instructive materials provide an exciting opportunity to modulate cell behavior and enhance the efficacy of cell-based approaches for musculoskeletal repair. However, the identification of critical instructive cues and how to present these stimuli is a focus of intense investigation. This review highlights recent biochemical and physical strategies used to engineer bio-instructive materials for the repair of musculoskeletal tissues, while also considering exciting progress in the engineering of immunomodulatory and antibacterial materials.
由于全球人口老龄化以及相关危险因素的增加,预计未来几年影响肌肉骨骼系统的疾病的患病率和成本将显著上升。尽管它是导致残疾的第二大原因,但治疗干预的临床选择仍然有限。细胞疗法治疗肌肉骨骼疾病的临床转化面临许多挑战,包括在恶劣的体内环境中维持细胞存活以及在植入后缺乏控制细胞表型的能力。为了解决这些挑战,开发能够调节细胞行为的生物指令材料已成为一种策略,旨在提高各种细胞群体的治疗潜力。然而,确定特定应用所需的必要线索以及这些信号应如何从生物材料呈现仍然难以捉摸。这篇综述强调了最近用于设计生物指令材料以修复肌肉骨骼组织的生化和物理策略。特别强调了正在进行的努力,例如免疫调节和抗菌材料的工程,以及将这些策略纳入生物制造和器官芯片方法中。
影响肌肉骨骼系统的疾病影响着各个年龄段的人,并对其活动能力和生活质量产生深远影响。虽然许多组织中的小缺陷可以成功愈合,但较大的缺陷通常无法愈合,或者愈合后会形成质量较差的纤维组织,需要临床干预。细胞疗法是临床转化的一个有前途的选择,但与维持细胞存活和指导植入后细胞表型相关的挑战限制了这种方法的成功。生物指令材料为调节细胞行为并提高细胞为基础的肌肉骨骼修复方法的疗效提供了一个令人兴奋的机会。然而,确定关键的指令线索以及如何呈现这些刺激是一个集中研究的焦点。这篇综述强调了最近用于设计生物指令材料以修复肌肉骨骼组织的生化和物理策略,同时还考虑了免疫调节和抗菌材料的令人兴奋的进展。